Clik here to view.
New Media – Feeds and Aggregators
The pharmaceutical industry has been slow to embrace new media. There are a number of good reasons for this. Any highly regulated industry, such as the pharmaceutical industry, has to be careful and...
View ArticleClik here to view.
Post Number 300 – Blog Monitoring
Welcome to my 300th posting! Sorry about yesterday – travel back from Europe had me running to catch up. Last March when I began this blog, I wrote a posting called "What People Are Saying About You...
View ArticleClik here to view.
New Media and Pharma – An Intermittent Series
As many of you know this is an intermittent series I’ve been writing on uses of new media by the pharmaceutical industry. So far, I’ve written about the use of Blog Monitoring, RSS Feeds for press...
View ArticleClik here to view.
New Media and Pharma – An Intermittent Series
Feed me! A few weeks ago, I was speaking to a group about pharmaceutical companies and new media. I have written posts on this blog about the slowness with which the industry has embraced new media –...
View ArticleClik here to view.
FEED ME – The Growing Use of Feeds
I thought it would be good to take a minute and talk about the growing use of feeds in pharma communications. I have commented in the past about feeds - for example that the U.S. is growing in its...
View ArticleClik here to view.
Social Media Tools and Strategy – A Webinar Coming Up
I was at a talk not long ago where two questions were posed by the speaker to the audience. First was – how many people have cell phones? Naturally everyone in the room raised their hand. The second...
View ArticleClik here to view.
What is PDUFA?
I used to have a much beloved co-worker who was not in healthcare, but upon hearing the term "PDUFA" – standing for the Prescription Drug User Fee Act – for the first time during a meeting, shouted...
View ArticleClik here to view.
When Does FDA Extend a PDUFA Date?
Today Eisai Inc. issued a press release entitled "Eisai Announces Extension of FDA Review of Drug Application for Investigational Agent Eribulin Mesylate". The company sites the reason for the...
View ArticleClik here to view.
The U.S. Pharmacopeia – What is it? What Does it Do?
One of the most frequent searches I see that people perform when coming to Eye on FDA is this – "Are Canadian Drugs Safe"? And safety, in this day and age, is the name of the game. As I've often...
View ArticleClik here to view.
What the Increasingly Granular Nature of Social Media Means for Communications
Last week I posted a few thoughts about how to get more out of medical meetings, inspired by the excellent work of some other bloggers I regularly read. Today, I’m posting a few thoughts about how...
View ArticleClik here to view.
Join Me for a Webinar – Communications Implications of the Sunshine Act Data
I don’t usually do adverts here on the blog – in fact never, but you may remember a posting I did a few months back on the communications implications of the Sunshine Act implementation. There is...
View Article
